Elevated proportion of collapsed microvessels indicate poor survival outcome in patients with non-small cell lung cancer

Y. Tong, Ying He, Luying Hu, Yu-jia Liu, Xiao-wei Zheng, Jiao Sun, Yu Song, Yiwen Zhang, L. Fang, Ping Huang
{"title":"Elevated proportion of collapsed microvessels indicate poor survival outcome in patients with non-small cell lung cancer","authors":"Y. Tong, Ying He, Luying Hu, Yu-jia Liu, Xiao-wei Zheng, Jiao Sun, Yu Song, Yiwen Zhang, L. Fang, Ping Huang","doi":"10.1177/0300891619871103","DOIUrl":null,"url":null,"abstract":"Background: An integral and well-functioning vascular system is essential for tumor progression and chemotherapy infusion. However, the lumen integrity of the microvessels and its significance in prognosis has not been studied. In this study, we found that the proportion of collapsed microvessels is suggested to be a novel biomarker for predicting prognosis in patients with non-small cell lung cancer (NSCLC). Methods: In this study, immunohistochemical CD31 staining was performed to identify the microvessels in tumor specimens. Proportions of collapsed vessels were estimated in CD31-stained tumor specimens from 100 patients with NSCLC. The correlation between collapsed microvessel proportion and survival time were evaluated by univariate and multivariate analysis. Results: Data from 99 patients were analyzed and a wide range of collapse–microvessel fraction was observed in 96 patients (1.4%–70%). Elevated collapse proportion (⩾6.5%) indicated poor overall survival in both univariate analysis (p = 0.042) and multivariate analysis (p = 0.014). Conclusions: Elevated proportion of collapsed microvessels indicted poor survival outcome in patients with NSCLC.","PeriodicalId":23450,"journal":{"name":"Tumori Journal","volume":"107 1","pages":"494 - 500"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumori Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0300891619871103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: An integral and well-functioning vascular system is essential for tumor progression and chemotherapy infusion. However, the lumen integrity of the microvessels and its significance in prognosis has not been studied. In this study, we found that the proportion of collapsed microvessels is suggested to be a novel biomarker for predicting prognosis in patients with non-small cell lung cancer (NSCLC). Methods: In this study, immunohistochemical CD31 staining was performed to identify the microvessels in tumor specimens. Proportions of collapsed vessels were estimated in CD31-stained tumor specimens from 100 patients with NSCLC. The correlation between collapsed microvessel proportion and survival time were evaluated by univariate and multivariate analysis. Results: Data from 99 patients were analyzed and a wide range of collapse–microvessel fraction was observed in 96 patients (1.4%–70%). Elevated collapse proportion (⩾6.5%) indicated poor overall survival in both univariate analysis (p = 0.042) and multivariate analysis (p = 0.014). Conclusions: Elevated proportion of collapsed microvessels indicted poor survival outcome in patients with NSCLC.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
微血管塌陷比例升高表明非小细胞肺癌患者生存预后差
背景:一个完整和功能良好的血管系统对肿瘤的进展和化疗输注至关重要。然而,微血管的管腔完整性及其对预后的意义尚未得到研究。在本研究中,我们发现微血管塌陷比例可能是预测非小细胞肺癌(NSCLC)患者预后的一种新的生物标志物。方法:采用免疫组织化学CD31染色法鉴定肿瘤标本中的微血管。在100例非小细胞肺癌患者的cd31染色肿瘤标本中估计了塌陷血管的比例。通过单因素和多因素分析评价微血管塌陷比例与生存时间的相关性。结果:对99例患者的数据进行分析,96例患者(1.4% ~ 70%)出现了大范围的微血管塌陷。在单因素分析(p = 0.042)和多因素分析(p = 0.014)中,崩溃比例升高(小于或等于6.5%)表明总生存期较差。结论:微血管塌陷比例升高提示非小细胞肺癌患者生存预后差。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs The digital revolution in pathology: Towards a smarter approach to research and treatment The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers bgicc 2024 abstracts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1